As another upregulated lncRNA which can be a possible therapeutic target for treatment of DLBCL patients, the lncRNA HULC can significantly increase the level of Bcl-2, and knockdown of HULC induced apoptosis of DLBCL cells [137]. The gene discussed is HULC; the disease is diffuse large B-cell lymphoma.